USANA Health Sciences Announces Plans to Expand into India
04 5월 2023 - 9:15PM
Business Wire
USANA Health Sciences, Inc. (NYSE: USNA) today announced its
plans to expand into India in the second half of 2023. Expansion
into India increases the Company’s global footprint to 25
markets.
“USANA’s expansion into India is our first new market in five
years and provides an exciting and gratifying opportunity to
introduce USANA’s world class health and wellness products to a new
country, culture and demographic,” said Jim Brown, President. “We
have spent several years of extensive research and meticulous work
to prepare for this expansion into India. We are confident that our
products and business model are ideally suited for India, and we
believe in our team’s ability to develop and grow this important
market as we work toward our vision of creating the healthiest
family on earth.
“While we are optimistic about the long-term growth opportunity
that India presents, we also recognize that there will be learning
opportunities as we serve an entirely new culture. As such, we will
take a deliberate and diligent approach to launching this market
and executing our long-term growth strategy.”
The Company expects to officially launch operations in India
near the end of the third quarter of 2023 and anticipates that this
new market will contribute modestly to sales during fiscal 2023.
The financial impact from India is reflected in the Company’s
fiscal 2023 net sales and diluted EPS guidance provided on April
25, 2023.
About USANA
USANA develops and manufactures high-quality nutritional
supplements, health foods and personal care products that are sold
directly to Associates and Preferred Customers throughout the
United States, Canada, Australia, New Zealand, Hong Kong, China,
Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the
Philippines, the Netherlands, the United Kingdom, Thailand, France,
Belgium, Colombia, Indonesia, Germany, Spain, Romania, and Italy.
More information on USANA can be found at www.usana.com.
Safe Harbor
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act. Our actual results could differ
materially from those projected in these forward-looking
statements, which involve a number of risks and uncertainties,
including: uncertainty related to the COVID-19 pandemic
(“COVID-19”) to our business, operations and financial results; the
potential for a resurgence of COVID-19 spread in any of our markets
in the future; the impact of COVID-19 on the domestic and world
economies, including any negative impact on discretionary spending,
consumer demand, and consumer behavior in general; regulatory risk
in China in connection with the health products and direct selling
business models; regulatory risk in the United States in connection
with the direct selling business model; potential negative effects
of deteriorating foreign and/or trade relations between the United
States and China; compliance with data privacy and security laws
and regulations in our markets around the world; potential negative
effects from geopolitical relations and conflicts, including the
Russia-Ukraine conflict; potential negative effects of material
breaches of our information technology systems to the extent we
experience a material breach; material failures of our information
technology systems; global economic conditions generally, including
increasing inflationary pressure around the world and any negative
impact on our operating costs, consumer demand and consumer
behavior in general; reliance upon our network of independent
Associates; risk associated with governmental regulation of our
products, manufacturing and direct selling business model; adverse
publicity risks globally; risks associated with our international
expansion and operations; and uncertainty relating to the
fluctuation in U.S. and other international currencies. The
contents of this release should be considered in conjunction with
the risk factors, warnings, and cautionary statements that are
contained in our most recent filings with the Securities and
Exchange Commission. The forward-looking statements in this press
release set forth our beliefs as of the date hereof. We do not
undertake any obligation to update any forward-looking statement
after the date hereof or to conform such statements to actual
results or changes in the Company’s expectations, except as
required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230504005348/en/
Investor contact: Andrew Masuda Investor Relations (801)
954-7210 investor.relations@usanainc.com
Media contact: Dan Macuga Public Relations (801) 954-7280
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024